YNYuka Nakajima

Yuka Nakajima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuka Nakajima has a total of 111 co-authors. Here are the top co-authors by number of shared publications:

  • Tasuku Honjo

    Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University

    3 shared publications
  • Kenji Chamoto

    Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan

    2 shared publications
  • Kensuke Akaogi

    Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan

    2 shared publications
  • Tsuyoshi Waku

    Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan

    2 shared publications
  • Akiko Fujimura

    Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba Science City, Ibaraki 305-8572, Japan

    1 shared publication
  • Akiko Kozaki

    Graduate School of Science and Technology, Shizuoka University, Ohya 836, Suruga-ku, Shizuoka 422-8021, Japan

    1 shared publication

Latest Publications

  • Top Cited Papers

    Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice

    by Muna Al-Habsi, Kenji Chamoto, Ken Matsumoto, Norimichi Nomura, Baihao Zhang, Yuki Sugiura, Kazuhiro Sonomura, Aprilia Maharani, Yuka Nakajima, Yibo Wu, et al.

    Spermidine (SPD) delays age-related pathologies in various organisms. SPD supplementation overcame the impaired immunotherapy against tumors in aged mice by increasing mitochondrial function and activating CD8 + T cells. Treatment of naïve CD8 + T cells with SPD acutely enhanced fatty acid oxidation. SPD conjugated to beads bound to the mitochondrial trifunctional protein (MTP). In the MTP complex, synthesized and purified from Escherichia coli , SPD bound to the α and β subunits of MTP with strong affinity and allosterically enhanced their enzymatic activities. T cell–specific deletion of the MTP α subunit abolished enhancement of programmed cell death protein 1 (PD-1) blockade immunotherapy by SPD, indicating that MTP is required for SPD-dependent T cell activation.


  • Top Cited Papers

    Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child

    by Masato Ogishi, Rui Yang, Caner Aytekin, David Langlais, Mathieu Bourgey, Taushif Khan, Fatima Al Ali, Mahbuba Rahman, Ottavia M. Delmonte, Maya Chrabieh, et al.

    The pathophysiology of adverse events following programmed cell death protein 1 (PD-1) blockade, including tuberculosis (TB) and autoimmunity, remains poorly characterized. We studied a patient with inherited PD-1 deficiency and TB who died of pulmonary autoimmunity. The patient’s leukocytes did not express PD-1 or respond to PD-1-mediated suppression. The patient’s lymphocytes produced only small amounts of interferon (IFN)-γ upon mycobacterial stimuli, similarly to patients with inborn errors of IFN-γ production who are vulnerable to TB. This phenotype resulted from a combined depletion of Vδ2+ γδ T, mucosal-associated invariant T and CD56bright natural killer lymphocytes and dysfunction of other T lymphocyte subsets. Moreover, the patient displayed hepatosplenomegaly and an expansion of total, activated and RORγT+ CD4−CD8− double-negative αβ T cells, similar to patients with STAT3 gain-of-function mutations who display lymphoproliferative autoimmunity. This phenotype resulted from excessive amounts of STAT3-activating cytokines interleukin (IL)-6 and IL-23 produced by activated T lymphocytes and monocytes, and the STAT3-dependent expression of RORγT by activated T lymphocytes. Our work highlights the indispensable role of human PD-1 in governing both antimycobacterial immunity and self-tolerance, while identifying potentially actionable molecular targets for the diagnostic and therapeutic management of TB and autoimmunity in patients on PD-1 blockade.


  • Critical role of the CD44 low CD62L low CD8 + T cell subset in restoring antitumor immunity in aged mice

    by Yuka Nakajima, Kenji Chamoto, Takuma Oura, Tasuku Honjo

    Significance: Although aging is known to suppress antitumor immunity, the precise underlying mechanism remains largely unknown. Here, we found that the inefficient generation of CD44 low CD62L low CD8 + T cell subset (P4), pre-effector–like T cells, could explain the resistance to PD-1 blockade antitumor therapy in aged mice. Elevated expression of CD45RB in aged naive CD8 + T cells appears to inhibit TCR signaling, resulting in fewer P4 cells, a subset with high expression of 1C metabolic genes. This decrease in P4 cells and antitumor activity was rescued by strong immunogenic stimulation by nonself cells. These findings provide valuable insights into the mechanism underlying age-induced suppression of antitumor immunity, which may provide a basis for the development of therapeutic strategies for elderly cancer patients.


  • Mechanism of Aloe vera gel on wound healing in human epidermis

    by Mariko Moriyama, Hirokazu Kubo, Yuka Nakajima, Arisa Goto, Junji Akaki, Ikuyo Yoshida, Yukio Nakamura, Takao Hayakawa, Hiroyuki Moriyama


  • Open Access

    NML-mediated rRNA base methylation links ribosomal subunit formation to cell proliferation in a p53-dependent manner

    by Tsuyoshi Waku, Yuka Nakajima, Wataru Yokoyama, Naoto Nomura, Koichiro Kako, Akira Kobayashi, Toshiyuki Shimizu, Akiyoshi Fukamizu

    Ribosomal RNAs (rRNAs) act as scaffolds and ribozymes in ribosomes, and these functions are modulated by post-transcriptional modifications. However, the biological role of base methylation, a well-conserved modification of rRNA, is poorly understood. Here, we demonstrate that a nucleolar factor, nucleomethylin (NML; also known as RRP8), is required for the N1-methyladenosine (m1A) modification in 28S rRNAs of human and mouse cells. NML also contributes to 60S ribosomal subunit formation. Intriguingly, NML depletion increases 60S ribosomal protein L11 (RPL11) levels in the ribosome-free fraction and protein levels of p53 through an RPL11–MDM2 complex, which activates the p53 pathway. Consequently, the growth of NML-depleted cells is suppressed in a p53-dependent manner. These observations reveal a new biological function of rRNA base methylation, which links ribosomal subunit formation to p53-dependent inhibition of cell proliferation in mammalian cells.


  • Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway

    by Yuka Nakajima, Asami Osakabe, Tsuyoshi Waku, Takashi Suzuki, Kensuke Akaogi, Tetsuya Fujimura, Yukio Homma, Satoshi Inoue, Junn Yanagisawa

    Estrogens are effective in the treatment of prostate cancer; however, the effects of estrogens on prostate cancer are enigmatic. In this study, we demonstrated that estrogen (17β-estradiol [E2]) has biphasic effects on prostate tumor growth. A lower dose of E2 increased tumor growth in mouse xenograft models using DU145 and PC-3 human prostate cancer cells, whereas a higher dose significantly decreased tumor growth. We found that anchorage-independent apoptosis in these cells was inhibited by E2 treatment. Similarly, in vivo angiogenesis was suppressed by E2. Interestingly, these effects of E2 were abolished by knockdown of either estrogen receptor β (ERβ) or Krüppel-like zinc finger transcription factor 5 (KLF5). Ιn addition, E2 suppressed KLF5-mediated transcription through ERβ, which inhibits proapoptotic FOXO1 and proangiogenic PDGFA expression. Furthermore, we revealed that a nonagonistic ER ligand GS-1405 inhibited FOXO1 and PDGFA expression through the ERβ-KLF5 pathway and regulated prostate tumor growth without ERβ transactivation. Therefore, these results suggest that E2 biphasically modulates prostate tumor formation by regulating KLF5-dependent transcription through ERβ and provide a new strategy for designing ER modulators, which will be able to regulate prostate cancer progression with minimal adverse effects due to ER transactivation.


  • PPARγ ligands suppress the feedback loop between E2F2 and cyclin-E1

    by Yoko Komatsu, Ichiaki Ito, Mitsutoshi Wayama, Akiko Fujimura, Kensuke Akaogi, Hikaru Machida, Yuka Nakajima, Takao Kuroda, Kazuji Ohmori, Akiko Murayama, et al.


  • Open Access

    A Flower-Inducing Substance of High Molecular Weight from Higher Plants

    by Go Takeba, Yuka Nakajima, Akiko Kozaki, Osamu Tanaka, Zenzaburo Kasai

    The flower-inducing activities of aqueous extracts of several plants were fractionated by gel filtration. Three major peaks, corresponding to molecular weights of about 120, 20 to 30, and 5 to 10 kilodaltons, were detected in extracts of Lemna, Pharbitis, and Brassica. The latter two peaks may be degradation products generated during the extraction procedure. In extracts of soybean seeds, only the peak of material of 120 kilodaltons was detected. This is the first published report of a high molecular mass substance with florigenic activity in Lemna plants. The florigenic substance had some properties associated with proteins (or polypeptides), but the activity was unaffected by treatment with proteinase K.